$TENX
TENAX THERAPEUTICS, INC. Stock $tenx

$tenx Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000165495421009088 Filed on August 16, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.640M	$1.271M	$1.940M
YoY Change	125.11%	46.26%	39.57%
% of Gross Profit
Research & Development	$1.162M	$693.2K	$890.0K
YoY Change	10.45%	-45.62%	-37.32%
% of Gross Profit
Depreciation & Amortization	$1.010K	$1.000K	$0.00
YoY Change	1.0%		-100.0%
% of Gross Profit
Operating Expenses	$3.802M	$1.965M	$2.830M
YoY Change	70.88%	-8.37%	0.71%
Operating Profit	$3.802M	$1.965M
YoY Change	70.88%	-8.37%
Interest Expense	$0.00	$336.00	$0.00
YoY Change
% of Operating Profit	0.0%	0.02%
Other Income/Expense, Net	$3.640K	-$247.8K	$0.00
YoY Change	-63.6%	-11895.34%	-100.0%
Pretax Income	-$3.799M	-$1.717M	-$2.830M
YoY Change	71.11%	-20.14%	1.43%
Income Tax
% Of Pretax Income
Net Earnings	$3.799M	$1.717M	-$2.830M
YoY Change	-271.08%	-179.99%	1.43%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$150.7K	-$99.72K	-$3.180M
COMMON SHARES
Basic Shares Outstanding	25.20M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.354M	$3.871M	$6.710M
YoY Change	-4.09%	-14.91%	24.26%
Cash & Equivalents	$8.354M	$1.671M	$6.250M
Short-Term Investments	$0.00	$2.200M	$460.0K
Other Short-Term Assets	$229.2K	$349.9K	$80.00K
YoY Change	20.61%	-46.99%	-89.74%
Inventory
Prepaid Expenses	$229.2K	$349.9K	$82.58K
Receivables
Other Receivables
Total Short-Term Assets	$8.583M	$2.532M	$6.796M
YoY Change	-3.56%	-51.4%	9.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.489K	$5.821K	$5.972K
YoY Change	-92.79%	-95.15%	-96.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.435K	$8.435K	$8.435K
YoY Change	-15.65%	-15.65%	-15.65%
Total Long-Term Assets	$328.4K	$353.0K	$73.19K
YoY Change	228.37%	152.11%	-61.48%
TOTAL ASSETS
Total Short-Term Assets	$8.583M	$2.532M	$6.796M
Total Long-Term Assets	$328.4K	$353.0K	$73.19K
Total Assets	$8.912M	$2.885M	$6.869M
YoY Change	-0.98%	-46.07%	7.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$776.2K	$791.9K	$757.9K
YoY Change	-26.07%	-49.23%	-54.35%
Accrued Expenses	$685.1K	$383.1K	$1.241M
YoY Change	128.37%	-26.33%	42.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$120.0K
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$1.461M	$1.175M	$2.119M
YoY Change	5.9%	-46.35%	-16.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$120.0K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$211.6K	$239.0K	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$211.6K	$239.0K	$124.2K
YoY Change	0.76%	70.74%	106.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.461M	$1.175M	$2.119M
Total Long-Term Liabilities	$211.6K	$239.0K	$124.2K
Total Liabilities	$1.673M	$1.414M	$2.243M
YoY Change	5.22%	-39.05%	-13.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$275.3M	-$271.5M	-$246.0M
YoY Change
Common Stock	$2.520K	$273.0M	$250.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.239M	$1.471M	$4.626M
YoY Change
Total Liabilities & Shareholders Equity	$8.912M	$2.885M	$6.869M
YoY Change	-0.98%	-46.07%	7.83%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q4
OPERATING ACTIVITIES
Net Income	$3.799M	$1.717M	-$2.830M
YoY Change	-271.08%	-179.99%	1.43%
Depreciation, Depletion And Amortization	$1.010K	$1.000K	$0.00
YoY Change	1.0%		-100.0%
Cash From Operating Activities	-$3.022M	-$1.846M	-$1.980M
YoY Change	26.42%	-17.21%	14.45%
INVESTING ACTIVITIES
Capital Expenditures	-$1.670K	-$1.880K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$513.2K	-$15.36K	$0.00
YoY Change	5032.2%	-176.8%	-100.0%
Cash From Investing Activities	$511.5K	-$17.23K	$0.00
YoY Change	5015.4%	-186.15%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$244.7K
YoY Change
Cash From Financing Activities	9.193M	4.650K	0.000
YoY Change	40.78%	-99.76%
NET CHANGE
Cash From Operating Activities	-3.022M	-1.846M	-1.980M
Cash From Investing Activities	511.5K	-17.23K	0.000
Cash From Financing Activities	9.193M	4.650K	0.000
Net Change In Cash	6.683M	-1.859M	-1.980M
YoY Change	61.03%	588.45%	13.14%
FREE CASH FLOW
Cash From Operating Activities	-$3.022M	-$1.846M	-$1.980M
Capital Expenditures	-$1.670K	-$1.880K	$0.00
Free Cash Flow	-$3.020M	-$1.844M	-$1.980M
YoY Change	26.35%	-17.29%	14.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	124166	USD
CY2021Q2	us-gaap	Liabilities Liabilities	1414049	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2243129	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	9999790	shares
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25201312	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1671422	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6250241	USD
CY2021Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	510943	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	462687	USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q2	us-gaap	Notes Payable NotesPayable	0	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	124166	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	239039	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	349862	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	82578	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	2532227	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	6795506	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	338698	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58778	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5821	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5972	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8435	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8435	USD
CY2021Q2	us-gaap	Assets Assets	2885181	USD
CY2020Q4	us-gaap	Assets Assets	6868691	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	791947	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	383063	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1175010	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239039	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25201312	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12619369	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2520	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1262	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	272953869	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	250644197	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-274	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-70	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-271484983	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-246019827	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1471132	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2885181	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6868691	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1271278	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	869206	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2644738	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2192165	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	693222	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1274837	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23069424	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2144043	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2617363	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1964500	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	2144043	USD
	us-gaap	Operating Expenses OperatingExpenses	25714162	USD
	us-gaap	Operating Expenses OperatingExpenses	4809528	USD
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	336	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1964500	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	406	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	949	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	406	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-249955	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8740	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1717016	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	2146550	USD
	us-gaap	Net Income Loss NetIncomeLoss	25465156	USD
	us-gaap	Net Income Loss NetIncomeLoss	4801194	USD
CY2021Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-128	USD
CY2020Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-3238	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	204	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1616	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1716888	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2143312	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25465360	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4799578	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.60
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17218103	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9339309	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15874062	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8156848	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3772497	USD
CY2020Q1	tenx	Common Stock And Pre Funded Warrants Sold Net Of Offering Costs Amount CommonStockAndPreFundedWarrantsSoldNetOfOfferingCostsAmount	2130005	USD
CY2020Q1	tenx	Compensation On Options Issued CompensationOnOptionsIssued	72376	USD
CY2020Q1	tenx	Common Stock Issued For Services Rendered Amount CommonStockIssuedForServicesRenderedAmount	100000	USD
CY2020Q1	tenx	Common Stock Issued For Convertible Preferred Stock Amount CommonStockIssuedForConvertiblePreferredStockAmount	0	USD
CY2020Q1	tenx	Exercise Of Pre Funded Warrants Amount ExerciseOfPreFundedWarrantsAmount	40	USD
CY2020Q1	tenx	Unrealized Loss On Marketable Securities UnrealizedLossOnMarketableSecurities	-1622	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-2654644	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3418652	USD
CY2020Q2	tenx	Compensation On Options Issued CompensationOnOptionsIssued	63166	USD
CY2020Q2	tenx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1690664	USD
CY2020Q2	tenx	Unrealized Gain On Marketable Securities UnrealizedGainOnMarketableSecurities	3238	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	3029170	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4625562	USD
CY2021Q1	tenx	Common Stock And Preferred Stock Issued For Asset Acquisition Amount CommonStockAndPreferredStockIssuedForAssetAcquisitionAmount	21582331	USD
CY2021Q1	tenx	Compensation On Options Issued CompensationOnOptionsIssued	91609	USD
CY2021Q1	tenx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	544651	USD
CY2021Q1	tenx	Unrealized Loss On Marketable Securities UnrealizedLossOnMarketableSecurities	-332	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23748140	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3095681	USD
CY2021Q2	tenx	Common Stock Issued For Convertible Preferred Stock Amount CommonStockIssuedForConvertiblePreferredStockAmount	0	USD
CY2021Q2	tenx	Compensation On Options Issued CompensationOnOptionsIssued	92339	USD
CY2021Q2	tenx	Unrealized Gain On Marketable Securities UnrealizedGainOnMarketableSecurities	128	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1471132	USD
	us-gaap	Profit Loss ProfitLoss	-25465156	USD
	us-gaap	Profit Loss ProfitLoss	-4801194	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2026	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2150	USD
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	949	USD
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	54223	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-247233	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q2	tenx	Available For Sale Securities Estimated Fair Value AvailableForSaleSecuritiesEstimatedFairValue	510943	USD
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	406	USD
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	53859	USD
	tenx	Issuance Of Common Stock And Preferred Stock For Asset Acquisition IssuanceOfCommonStockAndPreferredStockForAssetAcquisition	21582331	USD
	tenx	Issuance Of Common Stock And Preferred Stock For Asset Acquisition IssuanceOfCommonStockAndPreferredStockForAssetAcquisition	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	50000	USD
	tenx	Amortization Of Premium On Marketable Securities AmortizationOfPremiumOnMarketableSecurities	6896	USD
	tenx	Amortization Of Premium On Marketable Securities AmortizationOfPremiumOnMarketableSecurities	2647	USD
	tenx	Issuance And Vesting Of Compensatory Stock Options And Warrants IssuanceAndVestingOfCompensatoryStockOptionsAndWarrants	183948	USD
	tenx	Issuance And Vesting Of Compensatory Stock Options And Warrants IssuanceAndVestingOfCompensatoryStockOptionsAndWarrants	135542	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-267284	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	170046	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-923295	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-453406	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	6720	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-60379	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5066239	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4899965	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	345540	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	351138	USD
	tenx	Sale Of Marketable Securities SaleOfMarketableSecurities	290184	USD
	tenx	Sale Of Marketable Securities SaleOfMarketableSecurities	365049	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1875	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57231	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13911	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	544651	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1690704	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2130005	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	244657	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	544651	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4065366	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4578819	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-820688	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6250241	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4905993	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1671422	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4085305	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	333779	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	4773269	shares
	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	2.095
	tenx	Available For Sale Securities Gross Realized Gains Losses Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesProceeds	10000000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In preparing the unaudited condensed consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</p>
CY2021Q2	us-gaap	Marketable Securities MarketableSecurities	2200000	USD
CY2020Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	1500000	USD
CY2021Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	506530	USD
CY2021Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4690	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	46	USD
	tenx	Gross Unrealized Losses GrossUnrealizedLosses	-323	USD
	tenx	Schedule Of Investments In Marketable Securities ScheduleOfInvestmentsInMarketableSecurities	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="18" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortized </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accrued </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Interest</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Gross Unrealized Gains</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Gross Unrealized losses</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Corporate debt securities </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">506,530</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,690</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">46</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(323</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">510,943</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Total investments </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">506,530</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">4,690</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">46</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(323</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">510,943</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1671422	USD
CY2021Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	510943	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6250241	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	462687	USD
	us-gaap	Depreciation Depreciation	2000	USD
CY2021Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43033	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43033	USD
CY2021Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	23631	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	23307	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66664	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66340	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	60843	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	60368	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5821	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5972	USD
CY2021Q2	us-gaap	Depreciation Depreciation	1000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	127551	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	860629	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	154051	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	319608	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101461	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60379	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	383063	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1240616	USD
CY2015Q3	us-gaap	Area Of Land AreaOfLand	5954	sqft
	tenx	Lease Term Period LeaseTermPeriod	P64Y
	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	The Company has two five-year options to extend the Lease and a one-time option to terminate the Lease thirty-six months after the commencement of the initial term if no additional space (“Expansion Space”) became available. On April 2, 2021, the Company negotiated a 3-year extension to the existing lease term, commencing July 1, 2021
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	125034	USD
	tenx	Percentage Of Annual Increase In Rent PercentageOfAnnualIncreaseInRent	0.025	pure
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101461	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60379	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	239039	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	340500	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	60379	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	62517	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	126612	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	129797	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	65702	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	384628	USD
CY2021Q2	tenx	Less Imputed Interest LessImputedInterest	-44128	USD
	tenx	Remaining Lease Term RemainingLeaseTerm	P36Y
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080	pure
	us-gaap	Lease Cost LeaseCost	67765	USD
CY2021Q2	tenx	Ppp Loan Amount PppLoanAmount	244657	USD
CY2021Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0100	pure
CY2021Q2	tenx	Ppp Loan Monthly Payment PppLoanMonthlyPayment	31100	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	244657	USD
	tenx	Debt Instrument Decrease Forgiveness Accrued Interest DebtInstrumentDecreaseForgivenessAccruedInterest	2576	USD
	tenx	Common Stock Acquired CommonStockAcquired	1892905	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	10232000	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1212492	shares
	tenx	Percentage Of Preferred Stock Carries Voting Rights PercentageOfPreferredStockCarriesVotingRights	0.0499	pure
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	3369371	USD
	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	18212960	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	21582331	USD
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	0	USD
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	150000	USD
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-21732331	USD
	tenx	In Process Research And Development Expense InProcessResearchAndDevelopmentExpense	21582331	USD
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q2	tenx	Common Stock Shares Issue CommonStockSharesIssue	25201312	shares
CY2020Q1	tenx	Warrant To Purchase Of Common Stock Exercise Price WarrantToPurchaseOfCommonStockExercisePrice	1.1651
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1610313	shares
CY2020Q3	tenx	Common Stock Par Or Stated Value Per Shares CommonStockParOrStatedValuePerShares	1.0278
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	652313	shares
CY2020Q3	tenx	Warrant To Purchase Of Common Stock Exercise Price WarrantToPurchaseOfCommonStockExercisePrice	1.0277
CY2020Q3	tenx	Concurrent Private Placement Unregistered Prefunded Warrants To Purchas Common Stock ConcurrentPrivatePlacementUnregisteredPrefundedWarrantsToPurchasCommonStock	4607692	shares
CY2020Q3	tenx	Unregistered Common Stock Warrants To Purchase Common Stock UnregisteredCommonStockWarrantsToPurchaseCommonStock	7783616	shares
CY2020Q3	tenx	Unregistered Common Stock Warrants To Purchase Gross Proceeds UnregisteredCommonStockWarrantsToPurchaseGrossProceeds	8000000.0	USD
CY2020Q3	tenx	Unregistered Warrants Exercise Price UnregisteredWarrantsExercisePrice	0.903
CY2020Q3	tenx	Net Proceeds From Offerings After Deducting Placement Agent Fees And Other Direct Offering Expenses NetProceedsFromOfferingsAfterDeductingPlacementAgentFeesAndOtherDirectOfferingExpenses	6500000	USD
CY2020Q3	tenx	Common Stock Shares Issue CommonStockSharesIssue	5260005	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15797503	shares
CY2020Q4	tenx	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equitys Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquitysInstrumentsOutstandingNumber	16599079	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.29
	tenx	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	1.54
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.27
	tenx	Shares Available For Grant Table Textblock SharesAvailableForGrantTableTextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 1pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares Available </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>for Grant</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Balances, at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">356,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Additional shares reserved</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">750,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Options granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(328,750</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Balances, at June 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">777,750</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>

Files In Submission

Name	View Source	Status
0001654954-21-009088-index-headers.html	Edgar Link	pending
0001654954-21-009088-index.html	Edgar Link	pending
0001654954-21-009088.txt	Edgar Link	pending
0001654954-21-009088-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tenx-20210630.xsd	Edgar Link	pending
tenx-20210630_cal.xml	Edgar Link	unprocessable
tenx-20210630_def.xml	Edgar Link	unprocessable
tenx-20210630_lab.xml	Edgar Link	unprocessable
tenx-20210630_pre.xml	Edgar Link	unprocessable
tenx_10q.htm	Edgar Link	pending
tenx_10q_htm.xml	Edgar Link	completed
tenx_ex101.htm	Edgar Link	pending
tenx_ex311.htm	Edgar Link	pending
tenx_ex312.htm	Edgar Link	pending
tenx_ex321.htm	Edgar Link	pending
tenx_ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TENX
TENAX THERAPEUTICS, INC. Stock $tenx

2021 Q3 Form 10-Q Financial Statement

#000165495421009088 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TENX TENAX THERAPEUTICS, INC. Stock $tenx

2021 Q3 Form 10-Q Financial Statement

#000165495421009088 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TENX
TENAX THERAPEUTICS, INC. Stock $tenx